Elizabeth A. Garofalo, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 1,600 shares at $25.98 ($42K) on 2025-09-02, disclosed to the SEC on 2025-09-03.
Open-market sale of $42k ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |